Here is what the page “Why Trump’s Drug Price Promises Haven’t Reached Struggling Voters” contains. President Donald Trump has repeatedly touted his administration’s efforts to lower prescription drug prices, yet many Americans say they are still waiting for relief. From insulin to EpiPens, the cost of life-saving medications continues to climb, squeezing household budgets and forcing hard choices between medicine and other essentials. Insurance premiums and out-of-pocket costs have also risen, leaving patients frustrated despite White House claims of progress.
The gap between rhetoric and reality is especially stark in swing states like Pennsylvania and Michigan, where voters consistently rank healthcare affordability as a top concern. While the administration has advanced rules on drug importation and rebates, experts say the impact has been limited by legal challenges, industry pushback, and the slow pace of regulatory change. For the complete material, the listing points back to the source inside the network.